Immunocore Holdings (Immunocore Holdings) Institutional Ownership : 37.29% (As of May. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Immunocore Holdings's institutional ownership is 37.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Immunocore Holdings's Insider Ownership is 0.07%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Immunocore Holdings's Float Percentage Of Total Shares Outstanding is 87.75%.

Immunocore Holdings Institutional Ownership Historical Data

The historical data trend for Immunocore Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Institutional Ownership Chart

Immunocore Holdings Historical Data

The historical data trend for Immunocore Holdings can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	25.58	25.63	25.53	25.21	25.22	27.79	31.73	33.24	36.51	37.29

Immunocore Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.